grab from V-Dyne video

Jean Boulle Group’s VDYNE Heart Valve Technology Enrols First Patient in US Feasibility Study

Press Release Luxembourg, 24 April 2024 The Jean Boulle Group is pleased to note the announcement made by its Medtech device company VDYNE that it has initiated the United States early Feasibility Study (VISTA-US) for the evaluation of the performance of the Transcatheter Tricuspid Valve Replacement System for the treatment of tricuspid regurgitation. The announcement…